The effect of Nigella sativa on Meniere's disease

Phase 3

• Conditions: Meniere's disease.; Meniere's disease, unspecified ear; H81.09

• Registration Number: IRCT20201102049238N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients who are definite cases of Meniere's disease

Exclusion Criteria

History of cardiac disease
History of hepatic disease
History of renal disease
History of psychiatric disease
History of hypertension disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement of tinnitus. Timepoint: At the beginning of the study and 3 months after starting the consumption of Nigella sativa. Method of measurement: Tinnitus Handicap Inventory questionnaire.;Improvement of hearing loss. Timepoint: At the beginning of the study and 3 months after starting the consumption of Nigella sativa. Method of measurement: Audiometry.;Improvement of vertigo. Timepoint: At the beginning of the study and 3 months after starting the consumption of Nigella sativa. Method of measurement: Dizziness Handicap Inventory questionnaire.